Medication-Related Osteonecrosis of the Jaw (MRONJ)

نویسندگان

چکیده

Medication-related osteonecrosis of the jaw (MRONJ) is a rare but serious disease that can affect person's upper or lower jaw.1Feng Z Ann J Zhang Y Factors influencing severity medication-related jaw: retrospective study.J Oral Maxillofac Surg. 2021; 79: 1684-1689Abstract Full Text PDF Scopus (4) Google Scholar First described in 2002, it progressive death jawbone person exposed to medication known increase risk disease, absence previous radiation treatment. Such medications are used treat osteoporosis (brittle bones) cancer such as multiple myeloma. The most common bisphosphonates.2Ruggiero SL Dodson TB Fantasia et al.American Association and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis Jaw—2014 Update.J 2014; 72 (1938)Google MRONJ usually presents with bone mouth (Figure 1). This present an area dead after tooth extraction trauma. Some signs include:•Jaw pain•Redness your gum•Exposed bone•Non-healing socket•Numbness jaw•Loose teeth•A bad taste mouth•Swelling face affected gum You should contact dentist oral maxillofacial surgeon if you develop any these symptoms have concerns. best way prevent avoid having extracted often this cannot be avoided. Gum infection make patients more likely get MRONJ. Regular dental examination keeping up good health before, during, prescription very important need for emergent Ideally, teeth placement implants performed before starting medications. It may recommended stop taking sometime Your will coordinate physician. Sometimes treatment delayed until negative effect anti-resorptive reduced. If patient diagnosed MRONJ, surgery Hygiene measures reassessed reinforced order progression. steps include:•Daily irrigation antimicrobial rinse.•Antibiotics control progression disease.•Surgical intervention remove some advanced cases.•In patients, removable appliance cover protect sometimes recommended.•If dentures worn, minimizing irritation soft tissues done. RE: MEDICATION-RELATED OSTEONECROSIS OF THE JAW (MRONJ)Journal SurgeryVol. 80Issue 1PreviewWe read great interest contribute section “Simply Put: JOMS Information Patients” named “Medication-Related Jaw (MRONJ)” by Elie M. Ferneini.1 Full-Text

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Medication-Related Osteonecrosis of the Jaw

Osteonecrosis of the jaw (ONJ) is a common side effect of antiresorptive drugs that are administered to cancer patients for bone metastasis, multiple myeloma, and osteoporosis. Since both bisphosphonate (BP) and denosumab show anti-bone resorption effects with ONJ, antiresorptive agent-related ONJ (ARONJ) has been suggested as a comprehensive term encompassing both BP-related osteonecrosis of t...

متن کامل

Fibrous Dysplasia and Medication-Related Osteonecrosis of the Jaw.

PURPOSE Osteonecrosis of the jaw (ONJ) is an established side effect of intravenous bisphosphonates and other antiresorptive medications. Although bisphosphonates are frequently prescribed for patients with the skeletal disorder fibrous dysplasia (FD), there are no reports of ONJ in this population. This has led some to conclude that patients with FD are at low risk for the development of bisph...

متن کامل

Medication-related osteonecrosis of the jaws (MRONJ) and quality of life evaluation: a pilot study.

BACKGROUND MRONJ (medication related osteonecrosis of the jaws) is a well-known side effect of certain drugs, which are used to influence bone metabolism for the cure of osteo-metabolic or cancer diseases. The aim of this study is to assess the quality of life (QOL) under a physical and mental point of view in patients affected by MRONJ compared with the general population. METHODS The study ...

متن کامل

Role of Teriparatide in Medication-Related Osteonecrosis of the Jaws (MRONJ)

While the optimal treatment concept of medication-related osteonecrosis of the jaws (MRONJ) is still in debate, several adjunct therapies have been introduced. Among these adjunctive measures, recombinant human parathyroid hormone (rhPTH, teriparatide) seems to be the most promising treatment modality. Several studies have presented the beneficial effect of short-term teriparatide; they have sh...

متن کامل

Bisphosphonate-related osteonecrosis of the jaw

Bisphosphonates (BPs) have been used for the management of bone metabolic diseases. Currently their therapeutic use has increased, as also have their adverse effects, one of the most important being the bisphosphonate-related osteonecrosis of the jaw (BRONJ), a complication of diffi cult treatment and solution. Until now, the physiopathology of BRONJ remains unclear, and its treatment is uncert...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Journal of Oral and Maxillofacial Surgery

سال: 2021

ISSN: ['1531-5053', '0278-2391']

DOI: https://doi.org/10.1016/j.joms.2021.05.014